BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28740345)

  • 21. Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11.
    Cheng Y; Shi W; Cui X; Sun L; Nan Y; Yao H; Fan J; Zhu L; Yu L
    Dis Markers; 2022; 2022():7733390. PubMed ID: 35478990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype.
    Zhang X; Liu H; Xie Z; Deng W; Wu C; Qin B; Hou J; Lu M
    Sci Rep; 2016 May; 6():25389. PubMed ID: 27138288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues.
    Qiu D; Chen J; Liu J; Luo Z; Jiang W; Huang J; Qiu Z; Yue W; Wu L
    Exp Biol Med (Maywood); 2017 May; 242(9):939-944. PubMed ID: 28440732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
    Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
    World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by down-regulation of aquaporin 5.
    Zhang Z; Han Y; Sun G; Liu X; Jia X; Yu X
    Cell Mol Biol Lett; 2019; 24():13. PubMed ID: 30805015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
    Dai XQ; Cai WT; Wu X; Chen Y; Han FM
    Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.
    Li Z; Ma L; Di L; Lin X
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication.
    Pei R; Qin B; Zhang X; Zhu W; Kemper T; Ma Z; Trippler M; Schlaak J; Chen X; Lu M
    J Innate Immun; 2014; 6(2):182-91. PubMed ID: 23867918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
    Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
    J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
    Wang CM; Wang Y; Fan CG; Xu FF; Sun WS; Liu YG; Jia JH
    Biochem Biophys Res Commun; 2011 Aug; 411(3):586-92. PubMed ID: 21763284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells.
    Jung YJ; Kim JW; Park SJ; Min BY; Jang ES; Kim NY; Jeong SH; Shin CM; Lee SH; Park YS; Hwang JH; Kim N; Lee DH
    J Med Virol; 2013 Jun; 85(6):969-78. PubMed ID: 23532756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA-548ah promotes the replication and expression of hepatitis B virus by targeting histone deacetylase 4.
    Xing T; Zhu J; Xian J; Li A; Wang X; Wang W; Zhang Q
    Life Sci; 2019 Feb; 219():199-208. PubMed ID: 30615846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
    Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
    World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.
    Li MS; Lau TC; Chan SK; Wong CH; Ng PK; Sung JJ; Chan HL; Tsui SK
    PLoS One; 2011; 6(7):e21856. PubMed ID: 21814558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
    Huang KL; Lai YK; Lin CC; Chang JM
    World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.